The Bangladesh Journal of Pharmacology, published by the Bangladesh Pharmacological Society, is a leading platform dedicated to advancing knowledge in the field of pharmacology. With an ISSN of 1991-007X and an E-ISSN of 1991-0088, this open access journal has been making significant contributions to the field since its inception in 2006. Located at the Bangabandhu Sheikh Mujib Medical University in Dhaka, Bangladesh, the journal provides a vital resource for researchers, professionals, and students interested in pharmacology, toxicology, and pharmaceutics. As of 2023, the journal is categorized in the Q4 quartile for pharmacology, ranking 240th out of 313 in Scopus and falling within the 23rd percentile, reflecting its commitment to the dissemination of high-quality research. The journal encompasses a diverse array of topics from basic research to clinical applications, aiming to foster a deeper understanding of pharmacological principles and practices. By providing open access to its content, the Bangladesh Journal of Pharmacology ensures that valuable scientific findings are readily available to the global community, supporting the advancement of medical and pharmaceutical sciences.

CHEMICO-BIOLOGICAL INTERACTIONS is a premier journal published by Elsevier Ireland Ltd, dedicated to advancing the field of chemical and biological interactions since its inception in 1969. With a robust focus on pharmacology and toxicology, the journal holds a prestigious Q1 ranking in both Medicine (miscellaneous) and Toxicology, reflecting its significance in disseminating influential research. As part of the Scopus database, it ranks #21 out of 133 journals in Toxicology, positioning it in the 84th percentile and ensuring high visibility for cutting-edge studies. This scholarly platform serves as a crucial resource for researchers, professionals, and students who seek reliable and innovative findings at the intersection of chemistry and biology. While currently not open access, CHEMICO-BIOLOGICAL INTERACTIONS provides a comprehensive collection of articles that contribute to the ongoing dialogue in toxin research and its implications on medicinal chemistry, thereby fostering advancements in public health and safety.

Journal of Toxicology, published by HINDAWI LTD, stands as a pivotal open-access journal in the fields of toxicology and pharmacology since its inception in 2009. With an ISSN of 1687-8191 and an E-ISSN of 1687-8205, this journal is dedicated to disseminating high-quality research that critically examines the effects of toxic substances on living organisms. Located in Egypt and operating from their London office, it aims to provide an extensive platform for researchers worldwide to share findings that can inform better practices in safety and regulation. As of 2023, it has achieved significant recognition, holding a Q3 ranking in both the pharmacology and toxicology categories, and is indexed in Scopus with noteworthy percentile rankings (Toxicology: 57th and Pharmacology: 55th). With a focus on innovative studies and emerging areas such as environmental toxicology, biomarker research, and therapeutic interventions, the Journal of Toxicology invites both experienced researchers and students to contribute, thereby enhancing the breadth and depth of toxicological knowledge for the global scientific community.

Frontiers in Toxicology, published by Frontiers Media SA, is a prominent open-access journal dedicated to advancing the understanding of toxicological science. Established in 2019, it serves as a vital forum for innovative research, offering insights into the pharmacological impacts and toxicological profiles of various substances. With its international reach based in Switzerland, this journal has quickly ascended in the academic community, achieving a notable Q1 ranking in Pharmacology, Toxicology and Pharmaceutics (Miscellaneous) and a Q2 ranking in Toxicology as of 2023. The journal is indexed in Scopus, where it ranks #8 out of 43 in its primary category, underscoring its influence and relevance in the field. The scope encompasses cutting-edge studies on the mechanisms of toxicity, including both human and environmental impacts, making it an essential resource for researchers, professionals, and students alike. By promoting open access to high-quality research, Frontiers in Toxicology plays a crucial role in enhancing knowledge sharing and fostering collaboration across disciplines.

Inhalation Toxicology, published by Taylor & Francis Ltd, is a premier journal dedicated to advancing the field of toxicology with a particular focus on inhalation exposure and its impact on human health. Established in 1989, this journal provides a vital platform for original research, reviews, and case studies that explore the toxicological effects of inhaled substances, making it essential reading for researchers, health professionals, and regulatory scientists. With an Impact Factor that situates it in the Q3 category in both Health, Toxicology and Mutagenesis, the journal asserts its relevance within the scientific community, particularly emphasizing its contributions as indexed by Scopus rankings in related fields. Although it follows a traditional access model, the journal's commitment to delivering high-quality research continues to foster significant discussions and advancements in understanding inhalation toxicology. For those at the forefront of environmental science and pharmacology, Inhalation Toxicology is an indispensable resource for both current research and future innovations in the discipline.

Environmental Toxicology and Pharmacology, published by Elsevier, is a leading journal dedicated to advancing our understanding of the effects of environmental pollutants on biological systems. With an ISSN of 1382-6689 and an E-ISSN of 1872-7077, this journal covers a wide range of studies related to toxicology, pharmacology, and environmental health. The journal is classified as Q2 in key categories such as Health, Toxicology and Mutagenesis and Medicine (miscellaneous), and sits impressively in Q1 for Toxicology, reflecting its strong impact in the field. As of 2023, it ranks #30 out of 133 in Toxicology and #40 out of 148 in Health, indicating its high relevance and contribution to research. While the journal is not currently open access, it remains a pivotal resource for researchers, professionals, and students seeking to explore the intricacies of environmental health effects. Its commitment to publishing high-quality peer-reviewed research positions it as a crucial platform for scientific dialogue and discovery.

Drug Metabolism and Disposition is a premier journal published by the American Society for Pharmacology and Experimental Therapeutics, focusing on crucial advancements in the fields of pharmaceutical sciences and pharmacology. Since its inception in 1973, this esteemed journal has established itself as a leading platform for innovative research, earning a prestigious Q1 rating in both Pharmaceutical Science and Pharmacology categories as of 2023. With an impressive Scopus ranking of #52 out of 183 in Pharmaceutical Science and #105 out of 313 in Pharmacology, it occupies a vital place in an increasingly competitive academic landscape. Researchers, professionals, and students alike benefit from its rigorous peer-reviewed articles that delve into drug metabolism processes and their physiological implications, making it an indispensable resource for anyone aiming to advance their understanding of drug disposition and efficacy. This crucial journal contributes significantly to the ongoing dialogue in pharmacology and toxicology, providing insights that help shape future therapeutic strategies and regulatory policies.

TOXICOLOGY, published by Elsevier Ireland Ltd, is a prestigious peer-reviewed journal specializing in the field of toxicology. With an ISSN of 0300-483X and an E-ISSN of 1879-3185, this journal provides a vital platform for researchers, professionals, and students to disseminate and access groundbreaking studies from 1973 to present, with a convergence set until 2024. Recognized for its high impact, it holds a Q1 ranking in Toxicology category and ranks #18 out of 133 in Scopus's sector of Pharmacology, Toxicology, and Pharmaceutics, placing it in the 86th percentile. While the journal is not open access, it nonetheless offers a rich collection of research articles that enhance the understanding of toxicological science and its applications. The journal's objectives encompass advancing knowledge in the toxicological evaluation of substances, promoting safety in public health, and fostering dialogue among scholars. As a key resource in the field, TOXICOLOGY plays a crucial role in advancing research and informing practices related to toxicological risks and safety assessments.

Cutaneous and Ocular Toxicology, published by Taylor & Francis Ltd, is an essential resource in the fields of toxicology and pharmacology, focusing specifically on the effects of substances on the skin and eyes. With an ISSN of 1556-9527 and an E-ISSN of 1556-9535, this journal has been a vital platform for disseminating research since its inception in 1982, continuing its contributions to the scientific community through to 2024. Recognized for its academic rigor, it currently holds a Q3 ranking in the Medicine (miscellaneous) and Toxicology categories, reflecting its value among researchers and practitioners. The open access option enhances the journal's visibility and allows wider dissemination of knowledge, making it a key resource for professionals, students, and researchers dedicated to understanding and mitigating toxicological effects. Situated in the United Kingdom, Cutaneous and Ocular Toxicology strives to foster interdisciplinary collaboration and elevate the standards of toxicological research.

Toxicological Research is a prominent academic journal dedicated to advancing the field of toxicology through rigorous exploration and innovative research. Published by the Korean Society of Toxicology, this journal serves as a vital resource for researchers, professionals, and students engaged in environmental science, pharmacology, and toxicology. With an ISSN of 1976-8257 and an E-ISSN of 2234-2753, Toxicological Research highlights significant findings and discussions in the realm of health, toxicology, and mutagenesis. Although not an open-access journal, it maintains a solid reputation as evidenced by its Q3 ranking in both health-related toxicology and general toxicology categories for 2023. The journal covers a broad spectrum of topics from fundamental research to applied toxicology and provides a unique platform for the dissemination of knowledge in a field that is increasingly relevant in today’s society. With an anticipated convergence period from 2008 to 2024, Toxicological Research continues to contribute vital insights to understanding the implications of toxic substances on health and the environment.